Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

Biotech clinical laboratories are at the center of new medical discoveries, using tools like molecular biology and genetics ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors.

Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

The biotech's innovative qualities will come in handy. Long gone are the days when Moderna ( MRNA 2.66%) would generate over ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

Moderna may look appealing right now, given the company's high cash balance and extensive drug pipeline. However, as Moderna's cash burn dilemma persists, the company's net value will likely keep ...

The Middle East pharmaceutical market offers significant opportunities due to rising chronic diseases, local production ...

Flatiron Health today announced its presence at ISPOR—The Professional Society for Health Economics and Outcomes Research ...

Australia trains more PhDs than ever before—10,000 a year—but offers few places for them to work. A system built on perverse incentives rewards universities for producing scholars it won’t employ, ...